Dataset opportunity
Pixee Medical — 医疗影像数据集机会
Pixee Medical 持有的中等规模医疗影像数据集，可用于诊断AI和计算机视觉。
Score
72.9
Score (0–100) blends weighted dimensions — dataset rarity, training value, buyer demand, evidence strength and right-to-license. 70+ is deal-ready. See the scored dimensions below for the breakdown.Confidence
63%
Action
数据共享协议
The recommended deal structure for this dataset: Acquire (full buyout), License (paid usage rights), Data Sharing Agreement (controlled access, no transfer of ownership), Partnership (co-development) or Annotation Program (labeling). Chosen from data ownership, licensing complexity and accessibility.Market
全球医疗影像AI市场 = 2025年18亿美元，复合年增长率35.11% (2026-2033); 全球诊断AI市场 = 2025年19.7亿美元，复合年增长率21.74% (2026-2033)。
Recent dated external facts that triggered this opportunity — auditable provenance.
- 📰press2026-06-04
Can surgical robots fly? SS Innovations discusses challenges, solutions
therobotreport.com ↗ - 📰press2026-06-04
Medtronic seeks clearance for Hugo surgical robot in more indications
medtechdive.com ↗ - 📰press2026-06-02
Petal Surgical adds more funding for incisionless surgical robot
therobotreport.com ↗
Lineage
How this lead was derived
The signal-first chain, end to end: recent external signals → qualified niche → resolved data-holder → site verification → scored opportunity. Every lead is explainable.
Profile
Dataset profile
Type
医疗影像数据集
Modality
图像
Sector
医疗保健
Volume
中等
Freshness
实时
Rarity
高（专有）
Accessibility
受限
Legal
混合所有权 — GDPR敏感（个人身份信息审查）
Buyer persona
医疗AI和诊断影像公司
Pixee Medical 拥有一个极具价值的医学影像数据集（属于图像模态），并由 API、事件流、工业数据、物联网数据和医疗记录丰富。这一全面的真实世界患者数据集合非常适合训练和验证诊断AI模型，使其能够准确识别模式、进行预测并提供精确诊断。
此类数据的商业价值巨大，全球医学影像AI市场预计在2025年达到18亿美元，并预计到2033年达到202亿美元，2026年至2033年的复合年增长率（CAGR）为35.11%。同样，诊断AI市场在2025年估值为19.7亿美元，预计到2033年将增长到96.8亿美元，2026年至2033年的复合年增长率（CAGR）为21.74%。尽管有严格的 GDPR 和数据隐私法规要求匿名化和聚合，但AI开发对高质量训练数据的高需求使得该数据集对于推动医疗保健发展具有极高的价值。⚠ 尽职调查（有价值的数据，可协商访问）：严格的GDPR和医疗数据隐私法规适用；原始患者数据的所有权归医疗服务提供者/患者所有；数据访问可能需要匿名化和聚合。· 企业性质：独立。
Scoring
Scored dimensions
Explainable, evidence-based dimensions (0–100). The radar shows the investment axes.
Pixee Medical 拥有一个高度专有数据集，该数据集来源于在20多个国家进行的超过10,000例真实世界外科手术，使其异常稀有和有价值。这一丰富的数据集包括临床影像以及在智能眼镜辅助骨科手术期间捕获的独特时间序列操作数据。这种全面的多模态数据正是医疗AI和诊断影像公司训练和验证先进诊断AI和手术指导解决方案所需要的。随着全球医学影像AI和诊断市场蓬勃发展，该数据集为创新和竞争优势提供了关键且经过验证的基础。
See dimension details ↓- Dataset Specificity100
主导的“医疗记录”，医疗保健领域，4种特定类型
How sharply the data targets a specific, hard-to-substitute domain or task. Niche, well-defined data scores higher than generic. - Dataset Rarity94
专有领域数据
How scarce and proprietary the data is. Unique domain data scores high; openly available data lowers it. - Dataset Volume64
5个证据命中
Apparent scale of the data, inferred from the number of evidence hits and any explicit volume mentions. - Dataset Freshness82
实时/流式
How current the data stays — real-time/streaming scores highest, periodic dumps lower. - Training Value94
适用于诊断AI
How useful the data is for the target AI use-case — its fit for model training or fine-tuning. - Buyer Demand92
诊断AI对医学影像数据集的需求极高，这得益于医学影像AI市场预计从2025年的17.9亿美元增长到2034年的262.3亿美元，复合年增长率高达34.8%。
How strongly AI builders and companies are likely to want this data, based on market signals. - Legal Accessibility0
开放/API访问
How legally easy the data is to obtain and use — open/API access scores high; PII or regulated data scores low. - Acquisition Feasibility0
中等难度，独立
How realistic it is to actually obtain the data, given access difficulty and the holder's corporate structure. - Evidence Strength86
5种证据类型，5个命中
How solid the proof is that the company holds this data — diversity of evidence types and number of hits. - Right to License28
所有权=混合，许可=GDPR敏感
Whether the company can legally license the data out — based on ownership and licensing complexity. - Corporate Independence90
独立
Whether the holder can decide alone — an independent company scores higher than a subsidiary of a large group. - Data Orientation22
0个数据需求信号（0种类型）
How actively the company invests in data, measured by its data-appetite signals (hires, products, APIs…). - Dormant Data Surplus92
盈余=高，3个近期外部信号 — 超出已货币化部分的专有数据
Volume and value of proprietary data this company holds BEYOND what it already monetises — the dormant surplus we can unlock. A company can sell some insights AND still sit on a far larger dormant asset. - ICP Audit67
⚠ 审查 — Pixee Medical 的核心业务是销售提供手术智能和指导的增强现实软件解决方案，这属于销售智能/AI软件作为产品的排除标准。问题：该公司的核心业务是销售提供骨科手术智能和指导的AI软件（增强现实导航解决方案），直接
Evidence
Dataset evidence & lineage
What the typed evidence proves the company holds — reframed for clarity and set against the market.
IoT / sensor data
此证据证实了从手术器械和智能眼镜收集实时传感器数据，为手术导航AI提供精确的解剖标志定位，这一点至关重要。
Medical records / imaging
这直接证明了从超过10,000例外科手术中收集了大量的临床影像数据，展示了在20多个国家广泛的真实世界应用和影响，对于训练诊断AI至关重要。
Event streams
这强调了在骨科手术期间从智能眼镜捕获实时操作数据，详细说明了器械定位和外科医生互动，以提高手术效率。
Industrial data
这表明手术参数数据与增强现实可视化相结合的可用性，提供了对智能眼镜引导手术操作环境和增强现实集成的见解。
API access
这证实了与第三方网络解决方案进行安全、多模态数据交换的能力，表明了为可互操作数据集而设计的良好结构化和可访问的数据架构。
Marketplace
Dataset details
Geographic coverage
Global
Time range
Real-time
Update frequency
Real-time
Delivery
API, Event Streams
Formats
Image, Time-series, Medical Records
License
One-time license for training and validation of Diagnostic AI models. Specific usage restrictions apply.
Personal data
Contains PII
Indicative estimate, derived from public signals — not a quote, not contractual, and not agreed with the company. Is this your company? Correct it.
This dataset's value is driven by its high rarity as proprietary, multimodal medical imaging and operational data from over 10,000 surgical procedures. The strong demand from the rapidly growing AI in medical imaging and diagnostics markets, with CAGRs exceeding 20% and 35% respectively, supports a premium valuation.
Detailed schema & sample available on access request.
Want this data?
Request access — we broker a secure deal room. Operator-reviewed, no automatic sharing.
This listing was generated automatically from public signals. It is not verified, and we are not affiliated with this company.
Coverage
Scanned sources
Deliverable
Premium dataset report
Pixee Medical Medical Imaging — a Moderate medical imaging dataset (Image modality) in the healthcare domain. Primary AI use-case: Diagnostic AI. Market signal: Global AI in medical imaging market = USD 1.8 billion in 2025, CAGR 35.11% (2026-2033); Global AI in diagnostics market = USD 1.97 billion in 2025, CAGR 21.74% (2026-2033).. Investment score 72.9/100 (confidence 0.63). Recommended action: Data Sharing Agreement.
From the marketplace
Explore live data opportunities
Nrstor — 工业传感器数据集机会
View opportunity →工业Caliber — 维护日志数据集机会
View opportunity →移动Simarco — 移动遥测数据集机会
View opportunity →